TORONTO, Feb. 4, 2021 /CNW/ - Khiron Life Sciences Corp.
("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)
(Frankfurt: A2JMZC), a vertically
integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that
Alvaro Torres, Khiron CEO and
director, along with members of the Khiron management team, will
host a live webcast on Wednesday, February
17 at 11:00am ET to discuss
recent results and management's outlook for 2021.
Management will also be hosting a 1x1 Virtual Roadshow with
Harbor Access February 9-10, 2021 and
participating in the Benzinga Virtual Cannabis Capital Conference
being held February 25-26, 2021. In
addition, Mr. Torres will be participating in the Benzinga Cannabis
Hour on Thursday, February 11, 2021
as a panelist discussing the international cannabis landscape.
Khiron Investor Day Webcast: 2021
Outlook
Date: Wednesday, February 17, 2021
Time: 11:00am-12:00pm
ET
To register:
https://event.on24.com/wcc/r/3002371/132B51F89A277D8D1AADD6CDB47FD509
Harbor Access 1x1 Virtual Roadshow
Date:
February 9-10, 2021
To register: Email investors@khiron.ca to book 1x1
meeting
Benzinga Cannabis Hour: International
Cannabis
Date: Thursday,
February 11 at 4pm ET
To attend: http://bzcannabishour.com/
Benzinga Virtual Cannabis Capital
Conference
Date: February 25-26, 2021 at 1:30pm ET
To register:
https://events.benzinga.com/squeeze-page-422415971607984646162
Recent Company Highlights
- In 2020, achieves 50% compound monthly growth rate (CMGR) in
medical cannabis prescriptions (April to December), reaching 7,500
paid prescriptions as of January 31,
2021
- Colombian government extends medical health insurance coverage
to THC and CBD medical cannabis products, resulting in strong
month-over-month growth in December
2020 and January 2021
- On December 9th, Khiron opens new small-format
clinic in Medellin, Colombia's 2nd largest
city, as part of the Company's plan to extend its medical cannabis
clinics across Colombia and Latin America.
- Company appoints former Colombia Minister of
Finance Juan Carlos Echeverry as an independent member of
its Board of Directors
- Khiron declared a National Strategic Project by the Government
of Colombia, which simplifies and accelerates administration
processes for the Company's strategic initiatives
- Khiron is the first cannabis company in Colombia to
ship THC products internationally
About Khiron Life Sciences Corp.
Khiron is a
vertically integrated medical and CPG cannabis company with core
operations in Latin America, and
operational activity in Europe and
North America. Khiron is the
leading medical cannabis provider in Colombia and the first company licensed in
Colombia for the cultivation,
production, domestic distribution and sales, and international
export of both low and high THC medical cannabis products. The
Company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and is positioned to commence
sales of medical cannabis in Germany and Brazil in early 2021.
Leveraging wholly-owned medical clinics and proprietary
telemedicine platforms, Khiron combines a patient-oriented
approach, physician education programs, scientific expertise,
product innovation, and agricultural infrastructure to drive
prescriptions and brand loyalty. Its Wellbeing unit launched the
first branded CBD skincare brand in Colombia, with KuidaTM now marketed
in multiple jurisdictions in Latin
America, the US and UK. The Company is led by Co-founder and
Chief Executive Officer, Alvaro
Torres, together with an experienced and diverse executive
team and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram
@khironlife.
Cautionary Notes
Forward-Looking Statements
This press release may contain certain "forward-looking
information" and "forward-looking statements" within the meaning of
applicable securities legislation. All information contained herein
that is not historical in nature may constitute forward-looking
information. Khiron undertakes no obligation to comment on
analyses, expectations or statements made by third-parties in
respect of Khiron, its securities, or financial or operating
results (as applicable). Although Khiron believes that the
expectations reflected in forward-looking statements in this press
release are reasonable, such forward-looking statement has been
based on expectations, factors and assumptions concerning future
events which may prove to be inaccurate and are subject to numerous
risks and uncertainties, certain of which are beyond Khiron's
control, including the risk factors discussed in Khiron's Annual
Information Form which is available on Khiron's SEDAR profile at
www.sedar.com. The forward-looking information contained in this
press release is expressly qualified by this cautionary statement
and is made as of the date hereof. Khiron disclaims any intention
and has no obligation or responsibility, except as required by law,
to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
Neither the TSXV nor its Regulation Services Provider (as that
term is defined in the policies of the TSXV) accepts responsibility
for the adequacy or accuracy of this press release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/khiron-announces-live-webcast-and-upcoming-investor-events-301222084.html
SOURCE Khiron Life Sciences Corp.